Kendra Afonso Email & Phone Number

Waltham, Massachusetts, United States

Histology and Microscopy

United States

• Responsible for increasing company productivity by managing projects for documentation standardization and workflow improvement in clinical development, and clinical operations.
• Recognized by senior leaders for excellence in medical writing with positive communication in implementing problem-solving strategies in a fast-paced environment
• Enhanced productivity through standardization for reports, plans, validations, SOWs
• Introduced reporting automation, saving time and production costs, increasing revenue
• Retained key client and revenue by launching initiative to negotiate, standardize SOW writing and business management functions reducing out-of-scope work, managing deliverables
• Managed multiple cross-functional team projects

• Responsible for designing and leading strategic operations for pre-clinical rare disease and oncology projects in the global discovery pathology department
• Managed completion of key project milestones, deliverables working with senior leadership
• Collaborated with cross-functional leaders, staff to resolve problems, increase efficiency
• Authored SOPs, experimental protocols, monthly reports, corrective action reports for safety risk assessments ensuring compliance
• Provided company-wide support for optical microscopy, confocal microscopy, whole slide scanning
• Led team for critical milestone decisions on morphometry and data generation projects

• Responsible for biomarker research, image analysis producing critical morphometric data supporting the rare disease, neurology, and oncology drug development process for R&D pipeline, Phase I-IV clinical studies
• Key contributor for biomarker assay development and drug screening assays supporting essential corporate therapeutic programs, scientific abstracts and posters
• Proficient in microscopy methods: optical microscopy, confocal microscopy (3D z-stack, time-lapse, live cell imaging) whole slide scanning confocal and whole slide imaging technologies (Zeiss), Live cell and 3D.
• Recognized by senior leadership for achieving critical milestones in receptor and drug targeting mechanisms
• Provided decision-making data for pharmacology, toxicology, and pathology rare disease sub-committee investigations
• Mentored junior staff in immunofluorescence (IF), immunohistochemistry (IHC) methods

• Responsible for assay development, confocal imaging, and image analysis producing critical morphometric data supporting the rare disease, oncology drug development process for R&D pipeline
• Recognized by senior leadership for assay development in screening antibodies for critical milestones, confocal microscopy and whole slide imaging
• Increased productivity of immunohistochemistry and immunofluorescent methods using semi-automated antibody screening techniques
• Experience in histology methods: fixation, tissue processing, embedding, frozen and paraffin sectioning, glycol methacrylate sectioning, histochemical staining, special stains, whole brain sectioning, EM processing and.
• Recognized for expertise in manual and automated immunohistochemistry (IHC), immunofluorescence (IF) colocalization and confocal microscopy methods for R&D and clinical programs
• Responsible for data collection and analysis using MetaMorph, Definiens, and Visiopharm software

Bs, Clinical Laboratory Science Specializing In Chemistry

Marketing